Authors: Louden, C Morgan, DG

Citation: C. Louden et Dg. Morgan, Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entitiesfor human clinical trials, PHARM TOX, 89(4), 2001, pp. 158-170

Authors: Bochnowicz, S Osborn, RR Luttmann, MA Louden, C Hart, T Hay, DWP Underwood, DC

Citation: S. Bochnowicz et al., Differences in time-related cardiopulmonary responses to hypoxia in three rat strains, CLIN EXP HY, 22(5), 2000, pp. 471-492

Authors: Barker, SGE Sachs, R Louden, C Linnard, D Abu-Own, A Buckland, J Murphy, S

Citation: Sge. Barker et al., Integrated care pathways for vascular surgery, EUR J VAS E, 18(3), 1999, pp. 207-215

Authors: Treinen, KA Louden, C Dennis, MJ Wier, PJ

Citation: Ka. Treinen et al., Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits, TERATOLOGY, 59(1), 1999, pp. 51-59

Authors: Keenan, RM Lago, MA Miller, WH Ali, FE Cousins, RD Hall, LB Hwang, SM Jakas, DR Kwon, C Louden, C Nguyen, TT Ohlstein, EH Rieman, DJ Ross, ST Samanen, JM Smith, BR Stadel, J Takata, DT Vickery, L Yuan, CCK Yue, TL

Citation: Rm. Keenan et al., Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model, BIOORG MED, 8(22), 1998, pp. 3171-3176